chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After my 1st vaccine I developed a rash on my arms. My pap prescribed an ointment that didn't help with the itching. After my second vaccine, on March 12, (Moderna, 002B21A) the rash got worse, I had a biopsy and was diagnosed with Lichen Planus. I have a rash that continues to spread over both arms, my stomach, back, legs. I am now taking Prednisone. I have immense itching and a red rash that is unsightly!
Patient stated his arm was already sore and that he didn't feel very well. He stated he was short of breath and feeling hot. He tried to stand up and fell to the ground. He did not lose consciousness and was immediately given a dose of PO diphenhydramine liq 50 mg. He was taken to the ER for further observation. The ER doctor states that his diagnosis is a non-anaphylactic allergic reaction to the vaccine.
Roughly 16 hours after receiving the  first Moderna vaccine for COVID, woke up with  dizziness, loss of vision for a few minutes, shakiness, low grade fever, paleness, shaky walking ability, nausea, and loss of bowels in her clothing.
Pt woke up day after vaccination with rash and itching. Pt's left arm was swollen where if she touched her arm, there would be an slight indent. Patient took 2 tablets of Benadryl 25 mg. Upon examination on 9/17/15 her arm was not swollen, and it was not red.
SWEAT; ost many pounds; ositive for covid; could not eaT; tired; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT) and FATIGUE (tired) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No Medical History was reported). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) and IBUPROFEN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT), FATIGUE (tired), PYREXIA (fever) and CHILLS (chills). At the time of the report, HYPERHIDROSIS (SWEAT), WEIGHT DECREASED (ost many pounds), SARS-COV-2 TEST POSITIVE (ositive for covid), EATING DISORDER (could not eaT), FATIGUE (tired), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information include infusion.
Headache, Diarrhea, NauseaVomiting, chills, swollen glands Narrative:  Other Relevant History:
I was in a residential facility visiting my mother and was exposed to an individual that tested positive for COVID-19, I tested positive for COVID-19 myself two days later. I was prescribed PAXLOVID by my doctor and recovered from COVID-19 but I had a rebound case two days later. My right thumb turned purple during my rebound case and time and has stayed purple.
WHEN I LAY DOWN TO GO TO SLEEP I FEEL A TINGLING IN MY HAND AND WHEN I FALL ASLEEP I AM AWAKENED BY A BURNING SENSATION IN MY HAND . IT DOESNT GO AWAY UNTIL I GET UP AND MOVE AROUND. I CANT SLEEP OVER  2 HRS WITHOUT THE TINGLING AND BURNING SENSATION IN MY HANDS'  LAST YEAR I GOT STUNG BY A HORNET IN MY OTHER HAND AND STILL HAVE  CERTAIN FEELINGS IN THAT HAND.
My adverse reaction relates to my menstrual cycle. About a week after the first dose, I spotted for a day-I had never spotted before. Then the next cycle was unusual in that it was a few days late and very short. My next cycle was delayed by 3 weeks and since then, I?ve only had 1 more when I should have had at least 5. Each of those two have been heavy but short in duration.
During the 15minute waiting period, the 5th finger of  left arm (the arm where I received the shot) began to feel numb and cold. I tapped it on the chair to make sure circulation was going, and to make the sensation go away, moved arm around as well. Waited until 20minutes after the vaccine administration, before deciding it was safe to leave. Then numbness and cold feeling subsided. Never experienced this with any prior vaccines. Experiencing continued sore muscle in vaccine arm, as of 9/17/21
Severe fever; Body aches; Shivering; Pain in joints; This case was reported by a consumer and described the occurrence of fever in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (received 1st dose on an unknown date, refer case US2019AMR195115).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, general body pain, shivering and joint pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever, general body pain, shivering and joint pain were unknown.   It was unknown if the reporter considered the fever, general body pain, shivering and joint pain to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's husband. The age at vaccination was not reported. The patient experienced severe fever, body aces, shivering and pain in joints.
received nirmatrelvir-ritonavir therapy; received nirmatrelvir-ritonavir therapy; This is a literature report for the following literature source(s). A 31-year-old female patient (pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "received nirmatrelvir-ritonavir therapy". The patient underwent the following laboratory tests and procedures: Body mass index: 22.4 kg/m2; SARS-CoV-2 test: Positive, notes: mild-to-moderate COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: Reporter stated that  patients  received nirmatrelvir-ritonavir therapy from 16Apr2022, through 18May2022. Patients were eligible to receive nirmatrelvir-ritonavir if they were diagnosed with mild-to-moderate coronavirus disease 2019 (COVID-19) with symptom onset within 5 days, did not require oxygen therapy or hospital admission.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on limited information in the case , a possible causal association between   the reported events Drug ineffective , covid 19 and the suspect drug cannot be excluded.
Pt recvd 3 doses of Hep B vax & following 3rd dose pt exp sore arm, fatigue, nausea & h/a; sx subsided p/4 days;
Patient was fine receiving vaccine as well as during the 15 minute mandatory waiting period, however later that evening upon going home she complained of headache and leg pain.  Patient was instructed to contact PCP as soon as possible.
approx 4yrs p/vax pt devel chickenpox w/an unspecified number of lesions. no further info avail
Flu vaccine given in left deltoid.  Patient left to go back to work, came back to the clinic complaining of arm pain, numbness,
Hives, severe, with rapid onset; alleviated with liquid Benadryl; no respiratory sx
pt recvd flu vax & exp pain in the arm of inject which limited ROM; pt took ASA & applied heat & cold to the afflicted area;
Patient woke up in middle of night the following day after the vaccination with shaking, muscle weakness, dizziness, severe muscle soreness, and inability to walk.  Patient went to emergency room to rule out more serious complications.  All tests came out normal and was told the symptoms were a reaction to the vaccine.  The symptoms continued for 2 days, but eased up with time.  Patient was feeling normal 5 to 6 days after administration.
Headache, Fever, body aches, chills, nausea, lightheadedness, diaphoresis, fatigue, ear ache Narrative: employee states: began experiencing side effects approx 1230 on day 1. it began as dull body aches, headache, chills. around 2300 intense wave of nausea, lightheadedness and experienced alot of sweating, almost passed out (coworker described as pale) Had a low grade fever. The next morning (4/8/21) still had a slight fever, extreme fatigue, body aches, headache, bilateral earaches, and queasy. Day 3: dull body and ear aches, fatigue, chills, and queasy. Also noted some injection site pain
Per patient she developed several arm L pain to the point she can't raise above head. We were just notified of pain 10/30/09. Unable to determine if pain r/t back or just arm. Tn process for further evaluation.
covid vaccine sat fever came and went on sunday then fever started last night woke up in middle of night last night wiht 103 then around 630-7am noted rash started on chest and back, now spreading to arms, legs, up onto scalp and face temp 103-104 giving tylenol and iburpfoen
Fatigue; Headache; Body Aches; Chills; Hot Sweats; Cold sweats; Warm to touch; Dizziness; A spontaneous/solicited report was received from a physician concerning a, 24 year old, male patient who was participating in the mRNA-1273 Emergency Use Program and who experienced fatigue, headache, dizziness, body aches, chills, hot and cold sweats, and warm to touch. The patient indicated that he had Covid-19 in April 2020 and has antibodies.  The patient denies having any chronic medical history and is not taking any relevant concomitant medications.  On 26 Dec 2020, approximately one day prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the shoulder for prophylaxis of COVID-19 infection.   On 27 Dec 2020, the patient experienced fatigue, headache, dizziness, body aches, chills, hot and cold sweats, and warm to touch. Treatment for the events included paracetamol. He took Tylenol 1000mg 2 doses yesterday after receiving the vaccine and one dose of Tylenol 1000mg this morning. He was in a hurry to hang up, agent did not ask for Lot number.  The outcome of the events were not provided.   Action taken with mRNA-1273 in response to the events was not reported.   The reporter did not provide a causality assessment for the events, fatigue, headache, dizziness, body aches, chills, hot and cold sweats, and warm to touch.  Consent received to save callers information in our database, email information to him and for safety to follow up with him; Reporter's Comments: This case concerns a 24-years-old male patient, with past medical history of COVID-19 disease (April 2020) with antibodies, who experienced a non-serious unexpected event of pain, hyperhidrosis, cold sweat, skin warm, and dizziness, and non-serious expected event of fatigue, headache, and chills. All the events occurred 2 days after first dose of mRNA-1273, lot # unknown. Treatment included Tylenol 1,000mg.  Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.
Soreness; Stiffness; Red area; Knot on upper left arm; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In February 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain, stiffness, injection site erythema and local swelling. On an unknown date, the outcome of the injection site pain, stiffness, injection site erythema and local swelling were unknown.   It was unknown if the reporter considered the injection site pain, stiffness, injection site erythema and local swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced soreness, stiffness, red area of injection site, knot on upper left arm, after the 1st dose. The patient information was gathered.
Alot of pain. Had shivers at night with bad headache. Site is painful even today. There is redness and swelling 1-2 inches.
Fever and joint pain starting 6-1-19, Rash to neck on 6-3-19, Rash spreading to other areas on 6-4-19.
bad headache / the headache was in her forehead between the eyes; mild nausea; chills; bad taste; really tired; felt horrible; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 14Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious) with onset 15Mar2021, outcome "unknown", described as "bad headache / the headache was in her forehead between the eyes"; NAUSEA (non-serious) with onset 15Mar2021, outcome "unknown", described as "mild nausea"; CHILLS (non-serious) with onset 15Mar2021, outcome "unknown", described as "chills"; DYSGEUSIA (non-serious) with onset 15Mar2021, outcome "recovered", described as "bad taste"; FATIGUE (non-serious) with onset 15Mar2021, outcome "unknown", described as "really tired"; MALAISE (non-serious) with onset 15Mar2021, outcome "recovered", described as "felt horrible".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Injection site has started experiencing a burning pain when I move my arm in certain motions like pushing against something.  This has just started within the last few weeks and its been months since the last Injection.
small rash at site of injection; site of injection-red ring- rash / Shot was given in buttocks; Shot was given in buttocks; This case was reported by a other health professional via sales rep and described the occurrence of injection site rash in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site rash, injection site erythema and vaccine administered at inappropriate site. On an unknown date, the outcome of the injection site rash and injection site erythema were recovered/resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the injection site rash and injection site erythema to be related to Shingrix.     Additional Information: GSK receipt date: 31-Jan-2023 Reporter's comment: The reporter reported that the patient had small rash at site of injection red ring rash which was resolved. The shot was given in buttocks because other vaccines were given that day. Additional supportive information: As patient received vaccine on buttocks, which led to vaccine administered at inappropriate site.
was given influenza vaccine and developed 15mm multiple blisters to right deltoid. No treatment needed. No other signs or symptoms.
Allergic reaction; my leg was like just itching; This is a spontaneous report from a contactable consumer (Patient). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9269), via an unspecified route of administration on 10Feb2021 (at the age of 74-year-old) as dose number unknown, single for COVID-19 immunization. Medical history included hypertension from an unknown date and unknown if ongoing. Concomitant medication included furosemide (FUROSEMIDE) taken for an unspecified indication, start and stop date were not reported. On 11Feb2021 patient experienced leg was like just itching and allergic reaction on an unspecified date. It was reported that her height is about 5 Feet and 6 inches. She think and weight should be about 300 Pounds not positive about the weight." The only thing it says here is Pfizer and that number that she gave you and there is a date which was 02/10 and that is the only thing seeing except my name and birth date." Well, she took Zyrtec. Anyway so she did take Zyrtec this morning but that itching, she had taken that yesterday. That itching was something that was not usual." She queried Can you tell me is this something that would normally happen, a rash of any kind. I guess that is what I am concerned with." When Informed about the role of Pfizer Drug Safety again, she stated, "So, you do not have advice whether I should I be concerned about this or somewhere I should go to check this out." Patient did not underwent any lab test. She just need someone to tell her that if this is something to check out or is it something that normally happens. That is what it is. The itching is uncomfortable. she was unwilling to complete the report. Hence, limited information was available over the call. The outcome of the event was unknown.  Follow-up (21May2021): Follow-up attempts completed. No further information expected.
Fever; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 08Mar2021 (at the age of 40-years-old) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever on 08Mar2021. Therapeutic measures were taken as a result of fever and included treatment with Tylenol. She said that she heard that taking Tylenol might make vaccine less effective, so she wanted to find out if this is true. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a company representative who overheard a physician mention information concerning a patient who on an unknown date was vaccinated with a dose of GARDASIL (route, dose and lot number not provided). On an unknown date, the patient experienced "transverse mellitus" after getting GARDASIL which resulted in autoimmune hepatitis, which led to renal failure and liver transplant. The patient's outcome was unknown at the time of reporting. Upon internal review, myelitis transverse was considered to be an other important medical event. Attempts are being made to verify the existence of an identifiable patient and reporter. This is one of two reports from the same source.
Red itchy rash, skin firmness around vaccine, mild pain 8 days after vaccine shot.
itching around the injection site; chills; fever of 100 degrees; nausea; pain at the injection site on the right arm / pain at the injection site on the left arm; was injected in the right arm with the adjuvant solution only; injected / with the adjuvant solution only / nurse/ administered the correct mixture / in / left arm.; This case was reported by a consumer via call center representative and described the occurrence of chills in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 30th October 2020, less than a day after receiving Shingrix, the patient experienced nausea, injection site pain, inappropriate preparation of medication and inappropriate dose of vaccine administered. On 1st November 2020, the patient experienced chills and fever. On 2nd November 2020, the patient experienced injection site itching. On 1st November 2020, the outcome of the nausea was recovered/resolved. On an unknown date, the outcome of the chills, injection site pain and injection site itching were not recovered/not resolved and the outcome of the fever was recovered/resolved and the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the chills, fever, nausea, injection site pain and injection site itching to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the 1st dose of Shingrix and was injected in the right arm with the  adjuvant solution only which led Inappropriate preparation of medication and Inappropriate dose of vaccine administered. The patient reported itching around the injection site on the right arm that started on 2nd November 2020 and was still ongoing.  The patient reported pain at the injection site on the right arm that began on 30th October 2020 and was still ongoing but was subsiding.  The patient reported the nurse at doctor's office administered the correct mixture of Shingrix vaccine on 30th October 2020 in the patient's left arm.  The patient reported pain at the injection site on the left arm that started the same day the vaccine was given and is still ongoing today but is subsiding. The patient had a fever of 100 degrees and this had resolved.  The patient reported chills that began on 01st November 2020 and were still ongoing at this time of reporting. The reporter did not consent to follow up.
Upon calling to have patient come in for second dose, patient stated that she developed an orange sized red mark around the injection site that lasted almost 5 weeks and is still slightly visible (as of today 10/13).
LEFT ARM (VACCINATION ARM)UNABLE TO MOVE DULL HEADACHE LEFT ARM PAIN/ACHE FEVER 100F X36 HOURS ONE DAY MISSED WORK LISTLESS/TIRED X72 HOURS LOCAL TENDERNESS OF UPPER ARM X72 HOURS
I started feeling ill on May 4th, 2022, with a runny nose, body aches, fatigue, sore throat. I initially did a home COVID-19 Test that came back negative. On May 5, 2022 I woke up still feeling bad, I made an appointment with the clinic and had a PCR COVID-19 Test done. It came back positive and was prescribed Paxlovid on May 7th, 2022. I am not back to feeling one hundred percent but I am better than I was.
Large area of redness and swelling around injection area and now swelling and redness continuing down left arm/using ice and ibuprofen.
Information has been received from a physician concerning a 9 year old white male with no known medical history or allergies who on 14-Jun-1995 was vaccinated with a first dose of varicella virus vaccine live (lot #608655/0417B). On 17-Oct-2003 the patient developed varicella, which required a doctor's visit. Subsequently the patient recovered. No further information is expected.
Malaise,  persistent fever 99.3-101.8 defF. Chills, diarrhea, body aches. All since the vaccination day to present.
5 mins after 1st dose Pfizer, pt c/o cough, SOB, tight chest, tingling of tongue & scratchy throat.  EKG NSR.   Pt DC home stable condition 11:42
within 2 hours after the injection, I developed tingling and numbness in my left arm .  I retained the majority of sensation but there was a noticeable difference from normal sensation.  The initial symptoms lasted about 4 days, becoming progressively less noticeable until the tingling disappeared and the perception of numbness diminished past the point I noticed it.  I did not seek medical attention.  Since then, every few weeks my left arm will develop a tingle for 12-24 hours and a noticeable decrease in touch sensitivity in comparison to my right hand, similar sensation to wearing a thin glove on only one hand.  Each time I hope it's the last, but this has been going on for 6 months now which I find concerning.  I'm considering consulting a physician once I can afford to do so.